>>Ni-NTA His-Tag Purification Agarose

Ni-NTA His-Tag Purification Agarose

Catalog No.GC26302

Ni-NTA His-Tag Purification Agarose consists of nitrilotriacetic acid (NTA) chelator-activated agarose beads that subsequently charged with divalent nickel (Ni2+) ions by four coordination sites.

Products are for research use only. Not for human use. We do not sell to patients.

Ni-NTA His-Tag Purification Agarose Chemical Structure

Size 가격 재고 수량
5mL
US$52.00
재고 있음
10mL
US$86.00
재고 있음
50mL
US$320.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents

Ni-NTA His-Tag Purification Agarose consists of nitrilotriacetic acid (NTA) chelator-activated agarose beads that subsequently charged with divalent nickel (Ni2+) ions by four coordination sites.

The affinity chromatography purification reagent has low Ni2+ leakage, high protein-binding capacity and stability, and is compatible with a wide range of chemicals and pH values, making it ideal for high performance purification of polyhistidine-tagged proteins expressed in E.coli, yeast, insect and mammalian expression systems.

Product Features

Project

Features

Matrix

Highly cross-linked 6% agarose gel

Loading capacity

>40 mg 6 × His-tagged Protein/mL Settled Resin

Microsphere particle size

45-165 μm

Withstand maximum pressure

0.3 MPa, 3 bar

Storage buffer

Contains 20% ethanol 1×PBS

리뷰

Review for Ni-NTA His-Tag Purification Agarose

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Ni-NTA His-Tag Purification Agarose

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.